IAP regulation of metastasis.

Survivin and IAP proteins in cell-death mechanisms. Biochem J (2010) 2.18

Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis. J Cell Sci (2013) 1.63

A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. J Med Chem (2011) 1.58

Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein. J Biol Chem (2011) 1.54

Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest (2011) 1.41

ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer. Oncogene (2013) 1.40

Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer (2015) 1.39

IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation. EMBO J (2011) 1.36

MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition. Oncogene (2013) 1.29

Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J Clin Invest (2013) 1.28

Survivin is highly expressed in CD34(+)38(-) leukemic stem/progenitor cells and predicts poor clinical outcomes in AML. Blood (2012) 1.25

Targeting survivin overcomes drug resistance in acute lymphoblastic leukemia. Blood (2011) 1.24

Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) (2011) 1.22

MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res (2011) 1.21

MicroRNA-192 suppresses liver metastasis of colon cancer. Oncogene (2013) 1.20

X-linked inhibitor of apoptosis protein (XIAP) mediates cancer cell motility via Rho GDP dissociation inhibitor (RhoGDI)-dependent regulation of the cytoskeleton. J Biol Chem (2011) 1.17

Cell survival and metastasis regulation by Akt signaling in colorectal cancer. Cell Signal (2013) 1.17

Phosphanegold(I) thiolates, Ph3PAu[SC(OR)=NC 6H 4Me-4] for R = Me, Et and iPr, induce apoptosis, cell cycle arrest and inhibit cell invasion of HT-29 colon cancer cells through modulation of the nuclear factor-κB activation pathway and ubiquitination. J Biol Inorg Chem (2015) 1.13

Integrin αvβ3 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis. Cancer Res (2013) 1.10

A smac mimetic reduces TNF related apoptosis inducing ligand (TRAIL)-induced invasion and metastasis of cholangiocarcinoma cells. Hepatology (2010) 1.06

Survivin enhances motility of melanoma cells by supporting Akt activation and {alpha}5 integrin upregulation. Cancer Res (2010) 1.06

Phosphatase PRL-3 is a direct regulatory target of TGFbeta in colon cancer metastasis. Cancer Res (2010) 1.06

Identification of non-canonical NF-κB signaling as a critical mediator of Smac mimetic-stimulated migration and invasion of glioblastoma cells. Cell Death Dis (2013) 1.05

Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer. PLoS One (2011) 1.05

Apoptosis inhibitor ARC promotes breast tumorigenesis, metastasis, and chemoresistance. Cancer Res (2011) 1.05

The Chinese herb isolate isorhapontigenin induces apoptosis in human cancer cells by down-regulating overexpression of antiapoptotic protein XIAP. J Biol Chem (2012) 1.04

Survivin - The inconvenient IAP. Semin Cell Dev Biol (2015) 1.04

IAPs on the move: role of inhibitors of apoptosis proteins in cell migration. Cell Death Dis (2013) 1.01

Potent bivalent Smac mimetics: effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity. J Med Chem (2011) 1.00

The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer. Oncotarget (2015) 1.00

Small-molecule SMAC mimetics as new cancer therapeutics. Pharmacol Ther (2014) 0.99

Targeting survivin in cancer: novel drug development approaches. BioDrugs (2014) 0.98

MUC1-C oncoprotein confers androgen-independent growth of human prostate cancer cells. Prostate (2012) 0.97

Prognostic and clinicopathological significance of survivin in colorectal cancer: a meta-analysis. PLoS One (2013) 0.96

Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo. PLoS One (2011) 0.96

Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription. Mol Cancer (2014) 0.96

Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death. J Biol Chem (2011) 0.95

E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells. Pigment Cell Melanoma Res (2013) 0.95

Increased Notch signalling inhibits anoikis and stimulates proliferation of prostate luminal epithelial cells. Nat Commun (2014) 0.94

Survivin promotes oxidative phosphorylation, subcellular mitochondrial repositioning, and tumor cell invasion. Sci Signal (2015) 0.92

Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients. Oncol Lett (2013) 0.92

Regulation of lung cancer metastasis by Klf4-Numb-like signaling. Cancer Res (2013) 0.91

Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB. Apoptosis (2013) 0.91

LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling. Cancer Res (2012) 0.91

Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. Diagn Pathol (2012) 0.91

Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer. BMC Cancer (2014) 0.90

Integrin signaling in mammary epithelial cells and breast cancer. ISRN Oncol (2012) 0.88

E3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activity. PLoS One (2012) 0.87

A small molecule SMAC mimic LBW242 potentiates TRAIL- and anticancer drug-mediated cell death of ovarian cancer cells. PLoS One (2012) 0.87

Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. World J Gastroenterol (2015) 0.87

Elevated levels of uterine anti-apoptotic signaling may activate NFKB and potentially confer resistance to caspase 3-mediated apoptotic cell death during pregnancy in mice. Biol Reprod (2011) 0.86

Targeting antisense mitochondrial ncRNAs inhibits murine melanoma tumor growth and metastasis through reduction in survival and invasion factors. Oncotarget (2016) 0.85

Sticky siRNAs targeting survivin and cyclin B1 exert an antitumoral effect on melanoma subcutaneous xenografts and lung metastases. BMC Cancer (2013) 0.84

Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreen. PLoS One (2012) 0.84

The BIRC6 gene as a novel target for therapy of prostate cancer: dual targeting of inhibitors of apoptosis. Oncotarget (2014) 0.84

Survivin: a unique target for tumor therapy. Cancer Cell Int (2016) 0.84

Integrin-binding protein nischarin interacts with tumor suppressor liver kinase B1 (LKB1) to regulate cell migration of breast epithelial cells. J Biol Chem (2013) 0.84

WMJ-S-001, a novel aliphatic hydroxamate derivative, exhibits anti-angiogenic activities via Src-homology-2-domain-containing protein tyrosine phosphatase 1. Oncotarget (2015) 0.83

Inhibitor of Apoptosis Proteins: Promising Targets for Cancer Therapy. J Carcinog Mutagen (2013) 0.83

Ezrin expression and cell survival regulation in colorectal cancer. Cell Signal (2014) 0.83

Restoration of transforming growth factor-beta receptor II expression in colon cancer cells with microsatellite instability increases metastatic potential in vivo. J Biol Chem (2011) 0.83

In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer. Oncol Rep (2013) 0.82

Molecular alterations in key-regulator genes among patients with T4 breast carcinoma. BMC Cancer (2010) 0.82

Depletion of K-Ras promotes proteasome degradation of survivin. Cell Cycle (2013) 0.82

Differential PKA activation and AKAP association determines cell fate in cancer cells. J Mol Signal (2013) 0.82

Smac Mimetic-Induced Upregulation of CCL2/MCP-1 Triggers Migration and Invasion of Glioblastoma Cells and Influences the Tumor Microenvironment in a Paracrine Manner. Neoplasia (2015) 0.82

Anti-cancer activity of an osthole derivative, NBM-T-BMX-OS01: targeting vascular endothelial growth factor receptor signaling and angiogenesis. PLoS One (2013) 0.82

The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer. PLoS One (2013) 0.81

RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells. Am J Physiol Heart Circ Physiol (2011) 0.81

Smac mimetic SM-164 potentiates APO2L/TRAIL- and doxorubicin-mediated anticancer activity in human hepatocellular carcinoma cells. PLoS One (2012) 0.81

A potent bivalent Smac mimetic (SM-1200) achieving rapid, complete, and durable tumor regression in mice. J Med Chem (2013) 0.81

XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cells. Leuk Res (2013) 0.80

Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma. Br J Cancer (2016) 0.80

Intersecting pathways in inflammation and cancer: Hepatocellular carcinoma as a paradigm. World J Clin Oncol (2012) 0.80

Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance. Wien Klin Wochenschr (2014) 0.80

Oral Debio1143 (AT406), an antagonist of inhibitor of apoptosis proteins, combined with daunorubicin and cytarabine in patients with poor-risk acute myeloid leukemia--results of a phase I dose-escalation study. Clin Lymphoma Myeloma Leuk (2015) 0.79

Mechanism of the interaction between the intrinsically disordered C-terminus of the pro-apoptotic ARTS protein and the Bir3 domain of XIAP. PLoS One (2011) 0.79

Survivin expression in human lung cancer and the influence of its downregulation on the biological behavior of human lung cancer cells. Exp Ther Med (2012) 0.79

Plasma Fibronectin Promotes Tumor Cell Survival and Invasion through Regulation of Tie2. J Cancer (2013) 0.79

INPP4B suppresses prostate cancer cell invasion. Cell Commun Signal (2014) 0.79

IAPs as E3 ligases of Rac1: shaping the move. Small GTPases (2012) 0.79

Anti-cancer IAP antagonists promote bone metastasis: a cautionary tale. J Bone Miner Metab (2013) 0.78

Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling. Mutat Res (2014) 0.78

Ubiquitin-mediated regulation of RhoGTPase signalling: IAPs and HACE1 enter the fray. EMBO J (2012) 0.78

Endoplasmic Reticulum-resident Heat Shock Protein 90 (HSP90) Isoform Glucose-regulated Protein 94 (GRP94) Regulates Cell Polarity and Cancer Cell Migration by Affecting Intracellular Transport. J Biol Chem (2016) 0.78

Survivin isoforms and clinicopathological characteristics in colorectal adenocarcinomas using real-time qPCR. World J Gastroenterol (2011) 0.78

Inhibition of the integrin/FAK signaling axis and c-Myc synergistically disrupts ovarian cancer malignancy. Oncogenesis (2017) 0.78

Preclinical assesement of survivin and XIAP as prognostic biomarkers and therapeutic targets in gastroenteropancreatic neuroendocrine neoplasia. Oncotarget (2017) 0.77

Distinct Transcriptional Changes and Epithelial-Stromal Interactions Are Altered in Early-Stage Colon Cancer Development. Mol Cancer Res (2016) 0.77

(-)-Epigallocatechin-3-gallate Modulates the Differential Expression of Survivin Splice Variants and Protects Spermatogenesis During Testicular Torsion. Korean J Physiol Pharmacol (2013) 0.77

Survivin -31 G/C polymorphism might contribute to colorectal cancer (CRC) risk: a meta-analysis. Int J Clin Exp Med (2015) 0.77

[Molecular signaling pathways. Mechanisms and clinical use]. Strahlenther Onkol (2012) 0.77

High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy. Radiat Oncol (2012) 0.76

An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin. PLoS One (2013) 0.76

The twisted survivin connection to angiogenesis. Mol Cancer (2015) 0.76

The enigmatic roles of caspases in tumor development. Cancers (Basel) (2010) 0.76

An In Vivo Reporter to Quantitatively and Temporally Analyze the Effects of CDK4/6 Inhibitor-Based Therapies in Melanoma. Cancer Res (2016) 0.75

Chamaejasmenin B, a novel candidate, inhibits breast tumor metastasis by rebalancing TGF-beta paradox. Oncotarget (2016) 0.75

Regulation of XIAP Turnover Reveals a Role for USP11 in Promotion of Tumorigenesis. EBioMedicine (2016) 0.75

The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis. EBioMedicine (2017) 0.75

Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell (1995) 24.99

Tensional homeostasis and the malignant phenotype. Cancer Cell (2005) 19.30

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature (2005) 15.57

Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature (2000) 15.53

The Bcl2 family: regulators of the cellular life-or-death switch. Nat Rev Cancer (2002) 14.94

Genomic analysis of metastasis reveals an essential role for RhoC. Nature (2000) 10.11

Breast cancer metastasis: markers and models. Nat Rev Cancer (2005) 9.93

Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol (2006) 8.52

IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell (2007) 8.48

Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol (2006) 6.64

FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol (2000) 6.54

Genetic determinants of cancer metastasis. Nat Rev Genet (2007) 6.38

Anoikis mechanisms. Curr Opin Cell Biol (2001) 6.36

A renaissance for SRC. Nat Rev Cancer (2004) 6.27

Metastasis: a question of life or death. Nat Rev Cancer (2006) 6.26

Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer (2008) 5.65

Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol (2005) 5.00

NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev (2008) 4.61

Cell interactions with three-dimensional matrices. Curr Opin Cell Biol (2002) 4.34

Integrin regulation. Curr Opin Cell Biol (2005) 3.80

IAPs: what's in a name? Mol Cell (2008) 3.66

Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell (1997) 2.84

An IAP-IAP complex inhibits apoptosis. J Biol Chem (2004) 2.82

XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization. Mol Cell (2007) 2.21

Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature (2006) 2.12

Adaptation versus selection: the origins of metastatic behavior. Cancer Res (2007) 2.08

Final stages of cytokinesis and midbody ring formation are controlled by BRUCE. Cell (2008) 2.02

Increased beta1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res (2007) 1.86

Fibronectin expression modulates mammary epithelial cell proliferation during acinar differentiation. Cancer Res (2008) 1.81

Clonal selection of metastasis within the life history of a tumor. Cancer Res (2007) 1.74

A role for Drosophila IAP1-mediated caspase inhibition in Rac-dependent cell migration. Cell (2004) 1.69

X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-beta signaling. J Biol Chem (2001) 1.63

Association of an extracellular matrix gene cluster with breast cancer prognosis and endocrine therapy response. Clin Cancer Res (2008) 1.61

Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell (2007) 1.60

Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J Biol Chem (2003) 1.59

IKK epsilon regulates F actin assembly and interacts with Drosophila IAP1 in cellular morphogenesis. Curr Biol (2006) 1.57

Activation of NF-kappa B by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J Biol Chem (2000) 1.56

X-linked and cellular IAPs modulate the stability of C-RAF kinase and cell motility. Nat Cell Biol (2008) 1.55

Integrin regulation of cell signalling and motility. Biochem Soc Trans (2004) 1.53

FAK phosphorylation by ERK primes ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST. Mol Cell (2009) 1.47

Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin Cancer Res (2008) 1.46

Uncoupling of the signaling and caspase-inhibitory properties of X-linked inhibitor of apoptosis. J Biol Chem (2003) 1.41

Receptors that mediate cellular dependence. Cell Death Differ (2005) 1.37

Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc Natl Acad Sci U S A (1998) 1.35

Retracted Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem (2006) 1.22

B1 integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms. Apoptosis (2008) 1.22

Survivin is an independent predictor of short-term survival in poor prognostic breast cancer patients. Br J Cancer (2007) 1.19

A survivin gene signature predicts aggressive tumor behavior. Cancer Res (2005) 1.17

The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest (2000) 1.17

Detachment-induced upregulation of XIAP and cIAP2 delays anoikis of intestinal epithelial cells. Oncogene (2006) 1.11

Melanocyte expression of survivin promotes development and metastasis of UV-induced melanoma in HGF-transgenic mice. Cancer Res (2007) 1.10

Tumor-derived fibronectin is involved in melanoma cell invasion and regulated by V600E B-Raf signaling pathway. J Invest Dermatol (2006) 1.09

v-Src rescues actin-based cytoskeletal architecture and cell motility and induces enhanced anchorage independence during oncogenic transformation of focal adhesion kinase-null fibroblasts. J Biol Chem (2003) 1.04

c-Raf-mediated inhibition of epidermal growth factor-stimulated cell migration. J Biol Chem (1999) 1.03

Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis. J Cell Sci (2009) 1.00

ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. Cancer Cell (2010) 3.25

Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell (2007) 3.00

Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol (2005) 2.88

An IAP-IAP complex inhibits apoptosis. J Biol Chem (2004) 2.82

VEGF targets the tumour cell. Nat Rev Cancer (2013) 2.71

Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest (2005) 2.61

Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis. J Clin Invest (2004) 2.59

Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci (2002) 2.40

Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest (2005) 2.32

Survivin and molecular pathogenesis of colorectal cancer. Lancet (2003) 2.25

Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res (2002) 2.20

The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion. Mol Cell Biol (2005) 2.18

Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell (2003) 2.11

The epithelial-mesenchymal transition (EMT) and colorectal cancer progression. Cancer Biol Ther (2005) 2.10

Full-length dominant-negative survivin for cancer immunotherapy. Clin Cancer Res (2003) 2.00

A p34(cdc2) survival checkpoint in cancer. Cancer Cell (2002) 1.99

Alpha(v)beta3 integrin expression up-regulates cdc2, which modulates cell migration. J Cell Biol (2003) 1.97

Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res (2003) 1.95

Regulation of survivin function by Hsp90. Proc Natl Acad Sci U S A (2003) 1.86

Tumor cell dependence on Ran-GTP-directed mitosis. Cancer Res (2008) 1.83

Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma. Cancer Res (2004) 1.83

The integrin-growth factor receptor duet. J Cell Physiol (2007) 1.75

Regulation of microtubule stability and mitotic progression by survivin. Cancer Res (2002) 1.74

Rational design of shepherdin, a novel anticancer agent. Cancer Cell (2005) 1.74

Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90. J Clin Invest (2009) 1.72

Integrin (alpha 6 beta 4) regulation of eIF-4E activity and VEGF translation: a survival mechanism for carcinoma cells. J Cell Biol (2002) 1.66

Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin. Cancer Res (2005) 1.61

Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Mol Cell (2007) 1.60

Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J Biol Chem (2003) 1.59

Mobilization and activation of a signaling competent alpha6beta4integrin underlies its contribution to carcinoma progression. Cancer Metastasis Rev (2005) 1.58

Hsp60 regulation of tumor cell apoptosis. J Biol Chem (2007) 1.57

Survivin modulates microtubule dynamics and nucleation throughout the cell cycle. Mol Biol Cell (2006) 1.57

Integrins in prostate cancer progression. Endocr Relat Cancer (2008) 1.56

Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis. Clin Cancer Res (2003) 1.54

Developmental control of apoptosis by the immunophilin aryl hydrocarbon receptor-interacting protein (AIP) involves mitochondrial import of the survivin protein. J Biol Chem (2011) 1.54

Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis. Cancer Res (2003) 1.54

Proteases, extracellular matrix, and cancer: a workshop of the path B study section. Am J Pathol (2004) 1.52

Transcriptional regulation of VEGF-A by the unfolded protein response pathway. PLoS One (2010) 1.52

Survival responses of human embryonic stem cells to DNA damage. J Cell Physiol (2009) 1.51

Altered localization of p120 catenin during epithelial to mesenchymal transition of colon carcinoma is prognostic for aggressive disease. Cancer Res (2005) 1.49

A functional Notch-survivin gene signature in basal breast cancer. Breast Cancer Res (2008) 1.46

Inhibitor of apoptosis protein survivin regulates vascular injury. Nat Med (2002) 1.42

miR-10b targets Tiam1: implications for Rac activation and carcinoma migration. J Biol Chem (2010) 1.41

Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells. J Clin Invest (2011) 1.41

Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance. Clin Cancer Res (2008) 1.40

Acute ablation of survivin uncovers p53-dependent mitotic checkpoint functions and control of mitochondrial apoptosis. J Biol Chem (2003) 1.37

Flt-1-dependent survival characterizes the epithelial-mesenchymal transition of colonic organoids. Curr Biol (2003) 1.36

Survivin as a global target of intrinsic tumor suppression networks. Cell Cycle (2009) 1.36

GLI1 regulates a novel neuropilin-2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiation. EMBO Mol Med (2013) 1.33

Protein kinase C-alpha phosphorylation of specific serines in the connecting segment of the beta 4 integrin regulates the dynamics of type II hemidesmosomes. Mol Cell Biol (2004) 1.31

Landscape of the mitochondrial Hsp90 metabolome in tumours. Nat Commun (2013) 1.29

Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J Clin Invest (2013) 1.28

Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity. J Biol Chem (2005) 1.27

Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer. Am J Pathol (2009) 1.26

Regulation of beta 4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition. J Cell Sci (2009) 1.25

Transcriptional expression of survivin and its splice variants in brain tumors in humans. J Neurosurg (2003) 1.24

A role for ADAM12 in breast tumor progression and stromal cell apoptosis. Cancer Res (2005) 1.24

Molecular dependence of estrogen receptor-negative breast cancer on a notch-survivin signaling axis. Cancer Res (2008) 1.24

TRAP-1, the mitochondrial Hsp90. Biochim Biophys Acta (2011) 1.22

ADAM12 induces actin cytoskeleton and extracellular matrix reorganization during early adipocyte differentiation by regulating beta1 integrin function. J Cell Sci (2003) 1.21

Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res (2010) 1.19

Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by beta1 integrins. J Cell Biol (2004) 1.17

Activation of p53-dependent apoptosis by acute ablation of glycogen synthase kinase-3beta in colorectal cancer cells. Clin Cancer Res (2005) 1.17

A survivin gene signature predicts aggressive tumor behavior. Cancer Res (2005) 1.17

Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s. Cancer Cell (2012) 1.17

The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis. Exp Cell Res (2004) 1.16

ADAM12/syndecan-4 signaling promotes beta 1 integrin-dependent cell spreading through protein kinase Calpha and RhoA. J Biol Chem (2002) 1.16

Role of JNK in mammary gland development and breast cancer. Cancer Res (2011) 1.14

The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo. Cancer Res (2005) 1.14

beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts. Cancer Res (2005) 1.14

Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2. J Biol Chem (2008) 1.14

IMP3, a new biomarker to predict progression of cervical intraepithelial neoplasia into invasive cancer. Am J Surg Pathol (2011) 1.13

Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors. J Immunother (2007) 1.13

Mitosis-independent survivin gene expression in vivo and regulation by p53. Cancer Res (2006) 1.13

Activated checkpoint kinase 2 provides a survival signal for tumor cells. Cancer Res (2006) 1.12

Sorafenib exerts anti-glioma activity in vitro and in vivo. Neurosci Lett (2010) 1.12

Endogenous tumor suppression mediated by PTEN involves survivin gene silencing. Cancer Res (2009) 1.11

Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma. Cancer Res (2002) 1.10

Bone morphogenetic protein 7 protects prostate cancer cells from stress-induced apoptosis via both Smad and c-Jun NH2-terminal kinase pathways. Cancer Res (2006) 1.07

Antileukemic activity of shepherdin and molecular diversity of hsp90 inhibitors. J Natl Cancer Inst (2006) 1.06